Abstract
Longitudinal analysis of CBC and liver function post-treatment. (A) Total eosinophil (B) platelet and (C) lymphocyte counts quantified at days 0, 2, 4, 8, 15, 22, and 29 post-treatment (n = 3–5 per group). (D) Liver function assessed through the analysis of AST, ALT, and GGT levels over time at the same intervals (n = 3–5 per group). Data are expressed as mean ± SEM.